Pharmacokinetic and Pharmacodynamic Interactions Between Carbamazepine and Aripiprazole in Patients With SchizophreniaNAKAMURA, Akifumi; MIHARA, Kazuo; NAGAI, Goyo et al.Therapeutic drug monitoring. 2009, Vol 31, Num 5, pp 575-578, issn 0163-4356, 4 p.Article

Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patientsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; MIHARA, Kazuo et al.Journal of clinical psychopharmacology. 2003, Vol 23, Num 5, pp 435-440, issn 0271-0749, 6 p.Article

Effect of dietary fat content in meals on pharmacokinetics of quazepamYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; TAKAHATA, Takenori et al.Journal of clinical pharmacology. 2002, Vol 42, Num 12, pp 1335-1340, issn 0091-2700, 6 p.Article

Association between TAQ1 A dopamine D₂ receptor polymorphism and psychopathology of schizophrenia in Japanese patientsSUZUKI, Akihito; KONDO, Tsuyoshi; MIHARA, Kazuo et al.Progress in neuro-psychopharmacology & biological psychiatry. 2000, Vol 24, Num 7, pp 1105-1113, issn 0278-5846Article

Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidolSUZUKI, Akihito; YASUI-FURUKORI, Norio; MIHARA, Kazuo et al.Therapeutic drug monitoring. 2003, Vol 25, Num 2, pp 192-196, issn 0163-4356, 5 p.Article

The characteristics of side-effects of bromperidol in schizophrenic patientsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; ISHIDA, Masayuki et al.Psychiatry and clinical neurosciences (Carlton. Print). 2002, Vol 56, Num 1, pp 103-106, issn 1323-1316Article

Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19)CHRISTENSEN, Magnus; TYBRING, Gunnel; MIHARA, Kazuo et al.Clinical pharmacology and therapeutics. 2002, Vol 71, Num 3, pp 141-152, issn 0009-9236Article

Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patientsMIHARA, Kazuo; YASUI-FURUKORI, Norio; KONDO, Tsuyoshi et al.Therapeutic drug monitoring. 2002, Vol 24, Num 4, pp 563-566, issn 0163-4356Article

Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidolMIHARA, Kazuo; SUZUKI, Akihito; KONDO, Tsuyoshi et al.American journal of medical genetics. 2001, Vol 105, Num 3, pp 271-274, issn 0148-7299Conference Paper

The -141C Ins/Del polymorphism in the dopamine D₂ receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patientsSUZUKI, Akihito; KONDO, Tsuyoshi; MIHARA, Kazuo et al.Pharmacogenetics (London). 2001, Vol 11, Num 6, pp 545-550, issn 0960-314XArticle

Lack of Correlation Between the Steady-State Plasma Concentrations of Aripiprazole and Haloperidol in Japanese Patients With SchizophreniaNAKAMURA, Akifumi; MIHARA, Kazuo; NEMOTO, Kenji et al.Therapeutic drug monitoring. 2014, Vol 36, Num 6, pp 815-818, issn 0163-4356, 4 p.Article

Formulations of Valproate Alter Valproate Metabolism: A Single Oral Dose Kinetic StudyNAGAI, Goyo; ONO, Shingo; YASUI-FURUKORI, Norio et al.Therapeutic drug monitoring. 2009, Vol 31, Num 5, pp 592-596, issn 0163-4356, 5 p.Article

Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypesYASUI-FURUKORI, Norio; MIHARA, Kazuo; TAKAHATA, Takenori et al.British journal of clinical pharmacology. 2004, Vol 57, Num 5, pp 569-575, issn 0306-5251, 7 p.Article

Combination of dopamine D₂ receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patientsKONDO, Tsuyoshi; MIHARA, Kazuo; SUZUKI, Akihito et al.Progress in neuro-psychopharmacology & biological psychiatry. 2003, Vol 27, Num 6, pp 921-926, issn 0278-5846, 6 p.Article

Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepamYASUI-FURUKORI, Norio; TAKAHATA, Takenori; KONDO, Tsuyoshi et al.British journal of clinical pharmacology. 2003, Vol 55, Num 4, pp 382-388, issn 0306-5251, 7 p.Article

Associations between side effects of nemonapride and plasma concentrations of the drug and prolactinKONDO, Tsuyoshi; ISHIDA, Masayuki; TOKINAGA, Noboru et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 2, pp 287-291, issn 0278-5846Article

Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D₂ and D₃ receptors: A preliminary findingMIHARA, Kazuo; KONDO, Tsuyoshi; HIGUCHI, Hisashi et al.American journal of medical genetics. 2002, Vol 114, Num 6, pp 693-695, issn 0148-7299, 3 p.Article

Relationship Between Plasma Concentrations of Lamotrigine and Its Early Therapeutic Effect of Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive DisorderKAGAWA, Shoko; MIHARA, Kazuo; NAKAMURA, Akifumi et al.Therapeutic drug monitoring. 2014, Vol 36, Num 6, pp 730-733, issn 0163-4356, 4 p.Article

Effects of the CYP2D6*10 Allele on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With SchizophreniaSUZUKI, Takeshi; MIHARA, Kazuo; NAKAMURA, Akifumi et al.Therapeutic drug monitoring. 2011, Vol 33, Num 1, pp 21-24, issn 0163-4356, 4 p.Article

Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophreniaYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; SUZUKI, Akihito et al.Psychopharmacologia. 2002, Vol 162, Num 1, pp 63-66, issn 0033-3158Article

Lack of correlation between the steady-state plasma concentrations of haloperidol and risperidoneYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; MIHARA, Kazuo et al.Journal of clinical pharmacology. 2002, Vol 42, Num 10, pp 1083-1088, issn 0091-2700, 6 p.Article

No relationship between - 141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary studyMIHARA, Kazuo; KONDO, Tsuyoshi; SUZUKI, Akihito et al.Psychiatry research. 2001, Vol 101, Num 1, pp 33-38, issn 0165-1781Article

Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patientsMIHARA, Kazuo; KONDO, Tsuyoshi; SUZUKI, Akihito et al.Pharmacology & toxicology. 2001, Vol 88, Num 5, pp 267-270, issn 0901-9928Article